CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Revenues
Revenues	$ 2,530	$ 2,403	$ 4,789	$ 4,556
Expenses
Selling, general and administrative	894	832	1,761	1,626
Research and development	159	156	302	307
Amortization of intangible assets	256	270	512	544
Asset impairments	0	5	0	6
Restructuring, integration and separation costs	31	12	32	24
Other (income) expense, net	(18)	20	(3)	20
Total expenses	2,086	2,014	4,069	3,886
Operating income	444	389	720	670
Interest income	13	8	24	17
Interest expense	(465)	(350)	(795)	(705)
Gain on extinguishment of debt	178	12	178	23
Foreign exchange and other	(30)	(11)	(34)	(26)
Income (loss) before income taxes	140	48	93	(21)
Provision for income taxes	(12)	(49)	(51)	(57)
Net income (loss)	128	(1)	42	(78)
Net loss attributable to noncontrolling interest	20	11	48	24
Net income (loss) attributable to Bausch Health Companies Inc.	$ 148	$ 10	$ 90	$ (54)
Basic earnings (loss) per share attributable to Bausch Health Companies Inc. (in dollars per share)	$ 0.40	$ 0.03	$ 0.24	$ (0.15)
Diluted earnings (loss) per share attributable to Bausch Health Companies Inc. (in dollars per share)	$ 0.40	$ 0.03	$ 0.24	$ (0.15)
Basic weighted-average common shares (in shares)	370.9	367.9	370.3	367.4
Diluted weighted-average common shares (in shares)	373.1	370.2	373.5	367.4
Product sales
Revenues
Revenues	$ 2,504	$ 2,379	$ 4,731	$ 4,508
Expenses
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues	748	708	1,431	1,336
Other revenues
Revenues
Revenues	26	24	58	48
Expenses
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues	$ 16	$ 11	$ 34	$ 23